Wuhu Daorun Pharmaceutical

Wuhu Daorun Pharmaceutical is a specialized pharmaceutical company based in Wuhu, Anhui Province, China, focusing on the development and production of high-quality chemical drugs and active pharmaceutical ingredients (APIs). The company is recognized as a national high-tech enterprise and operates within a state-of-the-art facility that adheres to international GMP standards. Its primary therapeutic focus is on cardiovascular health, with a flagship product being Dronedarone Hydrochloride, an anti-arrhythmic medication used to treat atrial fibrillation. Daorun Pharmaceutical integrates advanced chemical synthesis technologies with rigorous quality control to supply both domestic and global markets. The firm maintains a robust R&D pipeline aimed at expanding its portfolio in metabolic and chronic disease management. Through its commitment to innovation and manufacturing excellence, the company has established itself as a key player in the Chinese specialty pharma sector.